Expression Profiling of Extramedullary Acute Myeloid Leukemia Suggests Involvement of Epithelial–Mesenchymal Transition Pathways

To test the functional impact of TWIST1 overexpression, scientists treated OCI-AML3s with TWIST1-siRNA or metformin, a drug known to inhibit tumor progression in cancer models.